Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2026-01-01 @ 10:48 PM
Study NCT ID:
NCT04925193
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-24
First Post:
2021-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma
Sponsor:
University of Colorado, Denver
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
20-2202.cc
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None